Jinlu Shang

Chengdu, 610400, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A Real-World Pharmacovigilance Analysis of HER2 Inhibitor-Induced Cardiovascular Toxicity.

A Real-World Pharmacovigilance Analysis of HER2 Inhibitor-Induced Cardiovascular Toxicity.

Journal: Oncology

Published: April 14, 2026

Mesoporous polydopamine-based biomimetic nanodelivery systems: recent advances in precision therapy.

Mesoporous polydopamine-based biomimetic nanodelivery systems: recent advances in precision therapy.

Journal: International journal of pharmaceutics

Published: March 02, 2026

An HSP90-inhibitory thermosensitive hydrogel enhances photothermal therapy against triple-negative breast cancer.

An HSP90-inhibitory thermosensitive hydrogel enhances photothermal therapy against triple-negative breast cancer.

Journal: Colloids and surfaces. B, Biointerfaces

Published: February 27, 2026

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

Journal: Cardiovascular toxicology

Published: September 30, 2025

Real-world pharmacovigilance analysis of depression associated with antineoplastic agents.

Real-world pharmacovigilance analysis of depression associated with antineoplastic agents.

Journal: Journal of affective disorders

Published: July 22, 2025

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database.

Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: a real-world pharmacovigilance analysis using the FAERS database.

Journal: Frontiers in pharmacology

Published: January 09, 2025

Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS.

Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS.

Journal: Frontiers in pharmacology

Published: November 16, 2024

A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy.

A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy.

Journal: International journal of nanomedicine

Published: October 21, 2024

Enhanced anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles for synergistic chemotherapy and photothermal therapy.

Enhanced anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles for synergistic chemotherapy and photothermal therapy.

Journal: International journal of pharmaceutics

Published: September 05, 2024

Advancements in Betulinic Acid-Loaded Nanoformulations for Enhanced Anti-Tumor Therapy.

Advancements in Betulinic Acid-Loaded Nanoformulations for Enhanced Anti-Tumor Therapy.

Journal: International journal of nanomedicine

Published: August 28, 2024

Biomimetic delivery of emodin via macrophage membrane-coated UiO-66-NH2 nanoparticles for acute pancreatitis treatment.

Biomimetic delivery of emodin via macrophage membrane-coated UiO-66-NH2 nanoparticles for acute pancreatitis treatment.

Journal: Biochemical and biophysical research communications

Published: January 26, 2024

Nano-scale drug delivery systems for luteolin: advancements and applications.

Nano-scale drug delivery systems for luteolin: advancements and applications.

Journal: Journal of materials chemistry. B

Published: November 21, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026